Inhibition of immunoglobulin E synthesis by a membrane fraction from Klebsiella pneumoniae (FMKP)

International Journal of Immunotherapy

Volumn 18, Issue 3-4, 2002, Pages 73-81

  Moine, V ^a   Corvaia N ^a   Libon, Christine ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARRIER PROTEIN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; KEYHOLE LIMPET HEMOCYANIN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; OLIGONUCLEOTIDE; OVALBUMIN; POLYMYXIN B;

ALLERGIC DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IN VIVO STUDY; INFLAMMATION; INTERFERON PRODUCTION; KLEBSIELLA PNEUMONIAE; MONOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SENSITIZATION;

EID: 0042195852     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Michel F.B., Dussourd d'Hinterland L., Bousquet J., Pinel A.M., Normier G. Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans. Infect. Immun., 20, 760, 1978.
2. Serrano E., Demanez J.P., Morgon A., Chastang C., Van Cauwenberge P. Effectiveness of ribosomal fractions of Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction of Kp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis. Results of a multicenter double-blind placebo-controlled study. Eur. Arch. Otorhinolaryngol., 254, 372, 1997.
3. Mora R., Barbieri M., Passali G.C., Sovatzis A., Mora F., Cordone M.P. A preventive measure for otitis media in children with upper respiratory tract infections. Int. J. Pediatr. Otorhinolaryngol., 63. 111, 2002.
4. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science, 272, 50, 1996.
5. Medzhitov R., Janeway C.A. Jr. Innate immunity: Impact on the adaptive immune response. Curr. Opin. Immunol., 9, 4, 1997.
6. Underhill D.M., Ozinsky A. Toll-like receptors: Key mediators of microbe detection. Curr. Opin. Immunol., 14, 103, 2002.
7. Jeannin P., Renno T., Goetsch L., et al. OmpA targets dendritic, cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat. Immunol., 1, 502, 2000.
8. Soulas C., Baussant T., Aubry J.P., et al. Outer membrane protein A (OmpA) binds to and activates human macrophages. J. Immunol., 165, 2335, 2000.
9. Jeannin P., Magistrelli G., Goetsch L., et al. Outer membrane protein A (OmpA): A new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. Vaccine, 20, 23, 2002.
10. Poltorak A., He X., Smimova I., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science, 282, 2085, 1998.
11. Re F., Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem., 276, 37692, 2001.
12. Rapp M.S. Can drug companies have it both ways? Can. Med. Assoc. J., 156, 982, 1997.
13. Vaz E.M., Vaz N.M., Levine B.B. Persistent formation of reagins in mice injected with low doses of ovalbumin. Immunology, 21, 11, 1971.
14. Jeannin P., Delneste Y., Lecoanet-Henchoz S., et al. Thiols decrease human interleukin (IL) 4 production and IL-4 induced immunoglobulin synthesis. J. Exp. Med., 182, 1785, 1995.
15. Claassen J.L., Levine A.D., Buckley R.H. A cell culture system that enhances mononuclear cell IgE synthesis induced by recombinant human interleukin-4. J. Immunol. Methods, 126, 213, 1990.
16. Chan S.H., Perussia B., Gupta J.W., et al. Induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J. Exp. Med., 173, 869, 1991.
17. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-gamma. Annu. Rev. Immunol., 15, 749, 1997.
18. Bohle B., Jahn-Schmid B., Maurer D., Kraft D., Ebner C. Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro. Eur. J. Immunol., 29, 2344, 1999.
19. Mancino D., Ovary Z. Adjuvant effects of amorphous silica and of aluminium hydroxide on IgE and IgG1 antibody production in different inbred mouse strains. Int. Arch. Allergy Appl. Immunol., 61, 253, 1980.
20. Beck L., Spiegelberg H.L. The polyclonal and antigen-specific IgE and IgG subclass response of mice injected with ovalbumin in alum or complete Freund's adjuvant. Cell Immunol., 123, 1, 1989.
21. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokine-CXC and CC chemokines. Adv. Immunol., 55, 97, 1994.
22. Rollins B.J. Chemokines. Blood, 90, 909, 1997.
23. Kimata H., Yoshida A., Ishioka C., Lindley I., Mikawa H. Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells. J. Exp. Med., 176, 1227, 1992.
24. Aksoy E., Amraoui Z., Goriely S., Goldman M., Willems F. Critical role of protein kinase C epsilon for lipopolysaccharide-induced IL-12 synthesis in monocyte-derived dendritic cells. Eur. J. Immunol., 32, 3040, 2002.
25. Gately M.K., Renzetti L.M., Magram J., et al. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses. Annu. Rev. Immunol., 16, 495, 1998.
26. Nakamura T., Kamogawa Y., Bottomly K., Flavell R.A. Polarization of IL-4- and IFN-gamma-producing CD4 T cells following activation of naive CD4 T cells. J. Immunol., 158, 1085, 1997.
27. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell., 89, 587, 1997.
28. Murphy E., Shibuya K., Hosken N., et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med., 183, 901, 1996.
29. Somasse T., Larenas P.V., Davis K.A., De Vries J.E., Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4 T cells analyzed at the single-cell level. J. Exp. Med., 184, 473, 1996.
30. Gereda J.E., Leung D.Y., Thatayatikom A., et al. Relation between house-dust endotoxin exposure, type I T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet, 355, 1680, 2000.
31. Shirakawa T., Enomoto T., Shimazu S., Hopkin J.M. The inverse association between tuberculin responses and atopic disorder. Science, 275, 77, 1997.
32. Bottcher M.F., Bjorksten B., Gustafson S., Voor T., Jenmalm M.C. Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin. Exp. Allergy, 33, 295, 2003.
33. Gehring U., Bolte G., Borte M., et al. Exposure to endotoxin decreases the risk of atopic eczema in infancy: A cohort study. J. Allergy Clin. Immunol., 108, 847, 2001.
34. Bousquet J., Becker W.M., Hejjaoui A., et al. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J. Allergy Clin. Immunol., 88, 43, 1991.
35. Ebner C., Siemann U., Bohle B., et al. Immunological changes during specific immunotherapy of grass pollen allergy: Reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin. Exp. Allergy., 27, 1007, 1997.
36. Secrist H., Chelen C.J., Wen Y., Marshall J.D., Umetsu D.T. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J. Exp. Med., 178, 2123, 1993.
37. Wiedermann U., Jahn-Schmid B., Fritsch R., et al. Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: Cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen. Clin. Exp. Immunol., 111, 144, 1998.
38. Yeung V.P., Gieni R.S., Umetsu D.T., DeKruyff R.H. Heat-killed Listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into Th1-dominated responses. J. Immunol., 161, 4146, 1998.